Results 111 to 114 of about 79,876 (114)

Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.

The Lancet Gastroenterology and Hepatology, 2017
M. Bazinet, V. Pantea, V. Cebotarescu, Lilia Cojuhari, P. Jimbei, J. Albrecht, P. Schmid, F. Le Gal, E. Gordien, A. Krawczyk, H. Mijočević, H. Karimzadeh, M. Roggendorf, A. Vaillant   +13 more
semanticscholar   +1 more source

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study.

The Lancet Oncology, 2012
K. Fizazi, H. Scher, A. Molina, C. Logothetis, K. Chi, Robert J. Jones, J. Staffurth, S. North, N. Vogelzang, F. Saad, P. Mainwaring, S. Harland, O. Goodman, C. Sternberg, J. H. Li, T. Kheoh, C. Haqq, J. D. de Bono   +17 more
semanticscholar   +1 more source

Separation of Pd(II) and Pt(IV) from hydrochloric acid solutions by solvent extraction with Cyanex 301 and LIX 63

, 2018
H. Truong, Man-Seung Lee
semanticscholar   +1 more source

Three kinds of Ganoderma lucidum polysaccharides attenuate DDC-induced chronic pancreatitis in mice.

Chemico-Biological Interactions, 2016
Koukou Li, Min Yu, Yang Hu, Guangming Ren, Tingting Zang, Xiuhong Xu, Juanjuan Qu   +6 more
semanticscholar   +1 more source